Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus

The G-protein-coupled receptor 40 agonist (GPR40) TAK-875 is being developed as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. Pharmacometric approaches such as model-based exposure-response and meta-analyses were applied to (i) characterize ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Naik, H, Lu, J, Cao, C, Pfister, M, Vakilynejad, M, Leifke, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600727/
https://www.ncbi.nlm.nih.gov/pubmed/23887592
http://dx.doi.org/10.1038/psp.2012.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600727/
https://www.ncbi.nlm.nih.gov/pubmed/23887592
http://dx.doi.org/10.1038/psp.2012.23

Ejemplares similares